What is Cytek Biosciences, Inc.'s total revenue?

Cytek Biosciences, Inc. (CTKB) reported total revenue of $44.14M in Q1 2026.

How has Cytek Biosciences, Inc.'s total revenue changed year-over-year?

Cytek Biosciences, Inc.'s total revenue increased by 6.5% year-over-year, from $41.46M to $44.14M.

What is the long-term trend for Cytek Biosciences, Inc.'s total revenue?

Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s total revenue has grown at a 12.0% compound annual growth rate (CAGR), from $127.95M to $201.49M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Cytek Biosciences, Inc. CTKB Total Revenue

Total Revenue at other companies

Becton, Dickinson and CompanyBDX

$4.71B+5.2%

Thermo Fisher ScientificTMO

$11.01B+6.2%

DanaherDHR

$5.95B+3.7%

Fulgent Genetics, Inc.FLGT

$71.14M-3.2%

10x Genomics, Inc.TXG

$150.84M-2.6%

TEC

Bio-TechneTECH

$311.42M-1.5%

Segments

By geography

See full

EMEA$10.77M-6.9%

APAC$7.75M-12.8%

Other$1.23M-50.0%

By segment

See full

Reportable Segment$44.14M+6.5%

By product

See full

Service$15.36M+15.1%

Other financials

Income statement

See full

Gross profit$21.3M+5.4%

Operating income-$18.5M-23.3%

Net income-$18.9M-65.5%

EPS (diluted)-$0.15-66.7%

Balance sheet

See full

Cash & equivalents$31.8M-66.6%

Total debt$16.8M+40.9%

Total equity$327.6M-13.7%

Total assets$449.1M-6.9%

Cash flow

See full

Operating cash flow-$2.7M-2,089%

CapEx$2.2M+155%

Free cash flow-$4.9M-403%

Valuation

See full

Market cap$577.27M+54.5%

Enterprise value$562.23M+93.7%

P/S2.8×+0.9×

Profitability

See full

Gross margin51.7%-3.2pp

Operating margin-21.5%—

Net margin-36.2%—

FCF margin-6.2%-15.1pp

Returns & leverage

See full

Return on equity-20.9%—

Debt / equity0.1×0.0×

Current ratio4.7×-0.9×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytek Biosciences, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cytek Biosciences, Inc.'s total revenue?: Cytek Biosciences, Inc. (CTKB) reported total revenue of $44.14M in Q1 2026.
How has Cytek Biosciences, Inc.'s total revenue changed year-over-year?: Cytek Biosciences, Inc.'s total revenue increased by 6.5% year-over-year, from $41.46M to $44.14M.
What is the long-term trend for Cytek Biosciences, Inc.'s total revenue?: Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s total revenue has grown at a 12.0% compound annual growth rate (CAGR), from $127.95M to $201.49M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.